Literature DB >> 23977537

Important recent insights into the genetics and biology of malignant pleural mesothelioma.

Robert McMillan1, Marjorie Zauderer, Matthew Bott, Marc Ladanyi.   

Abstract

Entities:  

Year:  2012        PMID： 23977537      PMCID： PMC3741788          DOI： 10.3978/j.issn.2225-319X.2012.10.09

Source DB:  PubMed          Journal:  Ann Cardiothorac Surg        ISSN： 2225-319X


× No keyword cloud information.
  28 in total

1.  BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.

Authors:  D E Jensen; M Proctor; S T Marquis; H P Gardner; S I Ha; L A Chodosh; A M Ishov; N Tommerup; H Vissing; Y Sekido; J Minna; A Borodovsky; D C Schultz; K D Wilkinson; G G Maul; N Barlev; S L Berger; G C Prendergast; F J Rauscher
Journal:  Oncogene       Date:  1998-03-05       Impact factor: 9.867

2.  Frequent mutation of BAP1 in metastasizing uveal melanomas.

Authors:  J William Harbour; Michael D Onken; Elisha D O Roberson; Shenghui Duan; Li Cao; Lori A Worley; M Laurin Council; Katie A Matatall; Cynthia Helms; Anne M Bowcock
Journal:  Science       Date:  2010-11-04       Impact factor: 47.728

3.  The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma.

Authors:  Matthew Bott; Marie Brevet; Barry S Taylor; Shigeki Shimizu; Tatsuo Ito; Lu Wang; Jenette Creaney; Richard A Lake; Maureen F Zakowski; Boris Reva; Chris Sander; Robert Delsite; Simon Powell; Qin Zhou; Ronglai Shen; Adam Olshen; Valerie Rusch; Marc Ladanyi
Journal:  Nat Genet       Date:  2011-06-05       Impact factor: 38.330

4.  Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.

Authors:  Guangwu Guo; Yaoting Gui; Shengjie Gao; Aifa Tang; Xueda Hu; Yi Huang; Wenlong Jia; Zesong Li; Minghui He; Liang Sun; Pengfei Song; Xiaojuan Sun; Xiaokun Zhao; Sangming Yang; Chaozhao Liang; Shengqing Wan; Fangjian Zhou; Chao Chen; Jialou Zhu; Xianxin Li; Minghan Jian; Liang Zhou; Rui Ye; Peide Huang; Jing Chen; Tao Jiang; Xiao Liu; Yong Wang; Jing Zou; Zhimao Jiang; Renhua Wu; Song Wu; Fan Fan; Zhongfu Zhang; Lin Liu; Ruilin Yang; Xingwang Liu; Haibo Wu; Weihua Yin; Xia Zhao; Yuchen Liu; Huanhuan Peng; Binghua Jiang; Qingxin Feng; Cailing Li; Jun Xie; Jingxiao Lu; Karsten Kristiansen; Yingrui Li; Xiuqing Zhang; Songgang Li; Jian Wang; Huanming Yang; Zhiming Cai; Jun Wang
Journal:  Nat Genet       Date:  2011-12-04       Impact factor: 38.330

5.  Merlin/NF2 suppresses tumorigenesis by inhibiting the E3 ubiquitin ligase CRL4(DCAF1) in the nucleus.

Authors:  Wei Li; Liru You; Jonathan Cooper; Gaia Schiavon; Angela Pepe-Caprio; Lu Zhou; Ryohei Ishii; Marco Giovannini; C Oliver Hanemann; Stephen B Long; Hediye Erdjument-Bromage; Pengbo Zhou; Paul Tempst; Filippo G Giancotti
Journal:  Cell       Date:  2010-02-19       Impact factor: 41.582

6.  The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression.

Authors:  Helen Yu; Nazar Mashtalir; Salima Daou; Ian Hammond-Martel; Julie Ross; Guangchao Sui; Gerald W Hart; Frank J Rauscher; Elliot Drobetsky; Eric Milot; Yang Shi; El Bachir Affar
Journal:  Mol Cell Biol       Date:  2010-08-30       Impact factor: 4.272

7.  Loss of the tumor suppressor gene NF2, encoding merlin, constitutively activates integrin-dependent mTORC1 signaling.

Authors:  Miguel A López-Lago; Tomoyo Okada; Miguel M Murillo; Nick Socci; Filippo G Giancotti
Journal:  Mol Cell Biol       Date:  2009-05-18       Impact factor: 4.272

8.  Global gene expression profiling of pleural mesotheliomas: overexpression of aurora kinases and P16/CDKN2A deletion as prognostic factors and critical evaluation of microarray-based prognostic prediction.

Authors:  Fernando López-Ríos; Shannon Chuai; Raja Flores; Shigeki Shimizu; Takatoshi Ohno; Kazuhiko Wakahara; Peter B Illei; Sanaa Hussain; Lee Krug; Maureen F Zakowski; Valerie Rusch; Adam B Olshen; Marc Ladanyi
Journal:  Cancer Res       Date:  2006-03-15       Impact factor: 12.701

9.  Germline BAP1 mutations predispose to malignant mesothelioma.

Authors:  Joseph R Testa; Mitchell Cheung; Jianming Pei; Jennifer E Below; Yinfei Tan; Eleonora Sementino; Nancy J Cox; A Umran Dogan; Harvey I Pass; Sandra Trusa; Mary Hesdorffer; Masaki Nasu; Amy Powers; Zeyana Rivera; Sabahattin Comertpay; Mika Tanji; Giovanni Gaudino; Haining Yang; Michele Carbone
Journal:  Nat Genet       Date:  2011-08-28       Impact factor: 38.330

10.  BAP1 loss defines a new class of renal cell carcinoma.

Authors:  Samuel Peña-Llopis; Silvia Vega-Rubín-de-Celis; Arnold Liao; Nan Leng; Andrea Pavía-Jiménez; Shanshan Wang; Toshinari Yamasaki; Leah Zhrebker; Sharanya Sivanand; Patrick Spence; Lisa Kinch; Tina Hambuch; Suneer Jain; Yair Lotan; Vitaly Margulis; Arthur I Sagalowsky; Pia Banerji Summerour; Wareef Kabbani; S W Wendy Wong; Nick Grishin; Marc Laurent; Xian-Jin Xie; Christian D Haudenschild; Mark T Ross; David R Bentley; Payal Kapur; James Brugarolas
Journal:  Nat Genet       Date:  2012-06-10       Impact factor: 38.330
View more
  3 in total

1.  The challenge of prognostic markers in pleural mesothelioma.

Authors:  Andrea Imperatori; Massimo Castiglioni; Lorenzo Mortara; Elisa Nardecchia; Nicola Rotolo
Journal:  J Thorac Dis       Date:  2013-06       Impact factor: 2.895

2.  Personalized oncogenomics: clinical experience with malignant peritoneal mesothelioma using whole genome sequencing.

Authors:  Brandon S Sheffield; Anna V Tinker; Yaoqing Shen; Harry Hwang; Hector H Li-Chang; Erin Pleasance; Carolyn Ch'ng; Amy Lum; Julie Lorette; Yarrow J McConnell; Sophie Sun; Steven J M Jones; Allen M Gown; David G Huntsman; David F Schaeffer; Andrew Churg; Stephen Yip; Janessa Laskin; Marco A Marra
Journal:  PLoS One       Date:  2015-03-23       Impact factor: 3.240

Review 3.  Switching off malignant mesothelioma: exploiting the hypoxic microenvironment.

Authors:  Noushin Nabavi; Kevin L Bennewith; Andrew Churg; Yuzhuo Wang; Colin C Collins; Luciano Mutti
Journal:  Genes Cancer       Date:  2016-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.